To our knowledge, this study is the first in which the associations between ABCB1 gene polymorphisms―rs1045642, rs1128503, rs2032582, and rs2235048―and adverse effects, specifically ANS dysfunction, in patients with schizophrenia were compared among atypical antipsychotics. This evidence concerns the gene ABCB1 and schizophrenia.